|
Antimony Potassium Tartrate
|
D000966 |
[A schistosomicide possibly useful against other parasites. It has irritant emetic properties and may cause lethal cardiac toxicity among other adverse effects.
] |
|
Hypolipidemic Agents
|
D000960 |
[Substances that lower the levels of certain LIPIDS in the BLOOD. They are used to treat HYPERLIPIDEMIAS.
] |
|
Brachyura
|
B01.050.500.131.365.190.110 |
|
|
Nasal Septum
|
D009300 |
[The partition separating the two NASAL CAVITIES in the midplane. It is formed by the SEPTAL NASAL CARTILAGE, parts of skull bones (ETHMOID BONE; VOMER), and membranous parts.
] |
|
Nasolacrimal Duct
|
D009301 |
[A tubular duct that conveys TEARS from the LACRIMAL GLAND to the nose.
] |
|
Diabetes Complications
|
D048909 |
[Conditions or pathological processes associated with the disease of diabetes mellitus. Due to the impaired control of BLOOD GLUCOSE level in diabetic patients, pathological processes develop in numerous tissues and organs including the EYE, the KIDNEY, the BLOOD VESSELS, and the NERVE TISSUE.
] |
|
CD79 Antigens
|
D12.776.124.790.651.950.500 |
|
|
Enthesopathy
|
C05.651.869.653 |
|
|
Vortioxetine
|
D03.383.606.990 |
|
|
Aliivibrio fischeri
|
D048908 |
[A species of gram-negative bacteria in the genus ALIIVIBRIO, which exhibits LUMINESCENCE. A. fischeri is found in a symbiotic relationship with the SQUID Euprymna scolopes.
] |
|
Antinematodal Agents
|
D000969 |
[Substances used in the treatment or control of nematode infestations. They are used also in veterinary practice.
] |
|
Synthetic Biology
|
J01.293.069.500 |
|
|
Spatial Regression
|
N06.850.520.830.933.375 |
|
|
Antibodies, Antinuclear
|
D000974 |
[Autoantibodies directed against various nuclear antigens including DNA, RNA, histones, acidic nuclear proteins, or complexes of these molecular elements. Antinuclear antibodies are found in systemic autoimmune diseases including systemic lupus erythematosus, Sjogren's syndrome, scleroderma, polymyositis, and mixed connective tissue disease.
] |
|
Leukapheresis
|
E05.242.363.171.570 |
|
|
Antioxidants
|
D000975 |
[Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues.
] |
|
Drug Resistance, Multiple, Viral
|
D024921 |
[The ability of viruses to resist or to become tolerant to several structurally and functionally distinct drugs simultaneously. This resistance phenotype may be attributed to multiple gene mutation.
] |
|
Antineoplastic Agents, Phytogenic
|
D000972 |
[Agents obtained from higher plants that have demonstrable cytostatic or antineoplastic activity.
] |
|
Antiparkinson Agents
|
D000978 |
[Agents used in the treatment of Parkinson's disease. The most commonly used drugs act on the dopaminergic system in the striatum and basal ganglia or are centrally acting muscarinic antagonists.
] |
|
alpha-2-Antiplasmin
|
D000979 |
[A member of the serpin superfamily found in plasma that inhibits the lysis of fibrin clots which are induced by plasminogen activator. It is a glycoprotein, molecular weight approximately 70,000 that migrates in the alpha 2 region in immunoelectrophoresis. It is the principal plasmin inactivator in blood, rapidly forming a very stable complex with plasmin.
] |
